USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS. Mediterr J Hematol Infect Dis [Internet]. 2010 Mar. 26 [cited 2026 Apr. 30];2(1):e2010003. Available from: https://www.mjhid.org/mjhid/article/view/2010.003